These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 13884424)

  • 1. [Spontaneous catalepsy in childhood. (Review of 10 cases)].
    DE NEGRI M; BERTAMINO F
    Riv Patol Nerv Ment; 1960; 81():717-28. PubMed ID: 13884424
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does the catalepsy phenomenon reflect the functional dopaminergic activity in pharmacological investigations?].
    Kozlovskiĭ VL
    Eksp Klin Farmakol; 2004; 67(3):3-6. PubMed ID: 15341057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of haloperidol on changes in development of spontaneous catalepsy during subchronic injections of dopamine agonists and antagonists].
    Kozlovskiĭ VL
    Patol Fiziol Eksp Ter; 2012; (3):75-80. PubMed ID: 23072116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of subchronic introduction of phenamine and haloperidol on development of spontaneous catalepsy in mice].
    Kozlovskiĭ VL; Prakh'e IV
    Patol Fiziol Eksp Ter; 2005; (4):22-5. PubMed ID: 16408663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two personal cases of catalepsy spontaneous upon awakening or hypnopompic numbness; necessary distinction between these states and catatonia].
    WOLFF E
    Ann Med Psychol (Paris); 1956 Jul; 114(2):283-90; discussion, 290-1. PubMed ID: 13340392
    [No Abstract]   [Full Text] [Related]  

  • 6. [Case of psychic trauma in hospitalized child].
    STAJIC S
    Srp Arh Celok Lek; 1957 Feb; 85(2):250-4. PubMed ID: 13455221
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of experimental elevation and decrease of thyroxine level on catalepsy in rats].
    Kulikov AV; Tikhonova MA; Lebedeva EI; Chuguĭ VF; Popova NK
    Ross Fiziol Zh Im I M Sechenova; 2004 Apr; 90(4):474-80. PubMed ID: 15296068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual complication following the use of trilafon in children.
    BERRY RV; KAMIN SH; KLINE A
    U S Armed Forces Med J; 1958 May; 9(5):745-50. PubMed ID: 13557160
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reflections in child pathology of semeiotic and pathogenetic problems related to catatonico-cataleptic syndromes].
    DE NEGRI M
    Minerva Pediatr; 1958 Dec; 10(48):1425-34. PubMed ID: 13632578
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats.
    Shimizu S; Tatara A; Sato M; Sugiuchi T; Miyoshi S; Andatsu S; Kizu T; Ohno Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():157-62. PubMed ID: 24368396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dopamine agonists and an opiate antagonist on agaricus-induced catalepsy, as tested by a new method.
    Sukul NC; Klemm WR
    Arch Int Pharmacodyn Ther; 1988; 295():40-51. PubMed ID: 2907723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic relationships between catalepsy and pendulum movements in rats].
    Kolpakov VG; Barykina NN; Alekhina TA; Chuguĭ VF; Popova NK; Zorkol'steva IV; Aksenovich TI
    Genetika; 1999 Aug; 35(8):1118-23. PubMed ID: 10546114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists.
    Hubbard CA; Trugman JM
    Mov Disord; 1993 Oct; 8(4):473-8. PubMed ID: 7901761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antihistamine drugs on the neuroleptic-induced catalepsy.
    Pawłowski L; Sidorowicz L
    Pol J Pharmacol Pharm; 1978; 30(5):665-73. PubMed ID: 35784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalepsy tests: what do they tell us?
    Weitzenhoffer AM
    Int J Clin Exp Hypn; 1996 Oct; 44(4):307-23. PubMed ID: 8885530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol-induced catalepsy: a model for screening antidepressants effective in treatment of depression with Parkinson's disease.
    Khisti RT; Mandhane SN; Chopde CT
    Indian J Exp Biol; 1997 Dec; 35(12):1297-301. PubMed ID: 9567763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic control of catalepsy in mice].
    Kulikov AV; Kozlachkova EIu; Popova NK
    Genetika; 1989 Aug; 25(8):1402-8. PubMed ID: 2583485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 5-hydroxytrytamine synthesis inhibitors on neuroleptic-induced catalepsy in rats.
    Sarnek J; Baran L
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):511-6. PubMed ID: 1172422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of piracetam, a cyclic GABA analogue, on haloperidol-induced catalepsy in the rat.
    Balsara JJ; Bapat TR; Chandorkar AG
    Indian J Physiol Pharmacol; 1980; 24(3):227-32. PubMed ID: 7193183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.